Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
November 16, 2022 | 1 - 3 p.m. CT
Although many tissues can replace lost or injured cells, neurons and cardiomyocytes lack regenerative capacity. Cellular reprogramming offers a novel cell therapy approach for the heart and central nervous system. This session will discuss approaches and tools for achieving cell lineage specification through reprogramming, noting both progress and pitfalls. This session will also address challenges that remain to improve efficiency and lead to potential therapeutic use.
This session is free for ASGCT Members and $50 for non-members.
Registrants & ASGCT Members: Watch On Demand
Moderators: Mollie Jacobs, PhD, (64x Bio) and Dan Peterson, PhD (Rosalind Franklin University)
Henrik Ahlenius, PhD Lund University
Aseem Ansari, PhD St. Jude’s Children Hospital
Li Qian, PhD University of North Carolina
January 22-23, 2025 | Virtual
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico